Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aptose Biosciences Inc.

    NASDAQ: APTO · Real-Time Price · USD
    1.71
    0.00 (0.00%)
    At close: Apr 01, 2025, 3:59 PM

    Aptose Biosciences Statistics

    Share Statistics

    Aptose Biosciences has 2.55M shares outstanding. The number of shares has increased by 3.36% in one year.

    Shares Outstanding

    n/a
    		 2.55M

    Shares Change (YoY)

    n/a
    		 3.36%

    Shares Change (QoQ)

    n/a
    		 9.12%

    Owned by Institutions (%)

    n/a
    		 0.11%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 818

    FTD / Avg. Volume

    n/a
    		 0.36%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -185.81 and the forward PE ratio is null. Aptose Biosciences's PEG ratio is 1.87.

    PE Ratio

    n/a
    		 -185.81

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 -1040.08

    P/FCF Ratio

    n/a
    		 -131.32

    PEG Ratio

    n/a
    		 1.87
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aptose Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.14, with a Debt / Equity ratio of -0.14.

    Current Ratio

    n/a
    		 2.14

    Quick Ratio

    n/a
    		 2.14

    Debt / Equity

    n/a
    		 -0.14

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-726,571.43

    Employee Count

    n/a
    		 35

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -95.33% in the last 52 weeks. The beta is 1.13, so Aptose Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.13

    52-Week Price Change

    n/a
    		 -95.33%

    50-Day Moving Average

    n/a
    		 3.47

    200-Day Moving Average

    n/a
    		 9.08

    Relative Strength Index (RSI)

    n/a
    		 42.5

    Average Volume (20 Days)

    n/a
    		 225,970

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 n/a

    Net Income

    n/a
    		 -25.43M

    EBITDA

    n/a
    		 n/a

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.04
    Full Income Statement

    Balance Sheet

    The company has 6.15M in cash and 621K in debt, giving a net cash position of 5.53M.

    Cash & Cash Equivalents

    n/a
    		 6.15M

    Total Debt

    n/a
    		 621K

    Net Cash

    n/a
    		 5.53M

    Retained Earnings

    n/a
    		 -540.97M

    Total Assets

    n/a
    		 10.13M

    Working Capital

    n/a
    		 5.07M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -35.98M and capital expenditures -5K, giving a free cash flow of -35.98M.

    Operating Cash Flow

    n/a
    		 -35.98M

    Capital Expenditures

    n/a
    		 -5K

    Free Cash Flow

    n/a
    		 -35.98M

    FCF Per Share

    n/a
    		 -0.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    APTO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for APTO is $93, which is 5338.6% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $93

    Price Target Difference

    n/a
    		 5338.6%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Feb 26, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -82.26

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist